Ondansetron Kalceks

Adults
Ondansetron is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy, and for the prevention and treatment of post-operative nausea and vomiting.

Paediatric population
In children over 6 months old and adolescents ondansetron is indicated for the management of chemotherapy-induced nausea and vomiting.
In children over 1 month old and adolescents ondansetron is indicated for the prevention and treatment of post-operative nausea and vomiting.

Prescription medication. Information for healthcare professionals only. For full information about the medicine, see the Summary of Product Characteristics.
Advertising developed or revised (02.2023). Advertiser: AS Kalceks.